Michelle Cellan, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 129a Hillside Ave, Williston Pk, NY 11596 Phone: 516-742-5243 |
Mrs. Elizabeth Balay, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 95 Custer Ave, Williston Pk, NY 11596 Phone: 516-519-2581 |
News Archive
Titan Pharmaceuticals, Inc. today announced that the National Institutes of Health has awarded the company a grant under the Small Business Innovation Research program supporting the development of a long-term, non-fluctuating dopamine agonist treatment for Parkinson's disease. The first year award in the amount of $300,000 will be available to Titan starting August 1, 2010, and an additional $195,000 for the second year starting August 1, 2011 has been recommended subject to availability of funds and satisfactory progress of the project. The grant will be administered by the National Institute of Neurological Disorders and Stroke.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
HOYA ConBio™, a global leader in dental and aesthetic lasers, today announced an extension of its sponsorship agreement with the Las Vegas Institute for Advanced Dental Studies (LVI), the pioneer in live-patient, post-graduate dental training. The agreement ensures that VersaWave™ and DioDent™ Micro 980 lasers will continue to be featured at LVI's advanced teaching facilities through 2013.
More poor children would get the flu vaccine if Medicaid increased the reimbursement to doctors for giving the shot, according to a new study published in the journal Pediatrics.
A combination of two devices could save the lives of several thousand cardiac arrest patients each year if implemented nationwide, suggests results of a clinical trial presented at today's American Heart Association Resuscitation Science Symposium.
› Verified 9 days ago